Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 2
2007 1
2008 5
2009 15
2010 33
2011 57
2012 72
2013 92
2014 112
2015 130
2016 186
2017 209
2018 262
2019 285
2020 333
2021 106
Text availability
Article attribute
Article type
Publication date

Search Results

1,636 results
Results by year

Citations

4 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ, Tschöpe C. Paulus WJ, et al. J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15. J Am Coll Cardiol. 2013. PMID: 23684677 Free article. Review.
Over the past decade, myocardial structure, cardiomyocyte function, and intramyocardial signaling were shown to be specifically altered in heart failure with preserved ejection fraction (HFPEF). A new paradigm for HFPEF development is therefore propose …
Over the past decade, myocardial structure, cardiomyocyte function, and intramyocardial signaling were shown to be specifically altered in h …
Heart failure with preserved ejection fraction: New approaches to diagnosis and management.
Upadhya B, Kitzman DW. Upadhya B, et al. Clin Cardiol. 2020 Feb;43(2):145-155. doi: 10.1002/clc.23321. Epub 2019 Dec 26. Clin Cardiol. 2020. PMID: 31880340 Free PMC article. Review.
The majority of older patients who develop heart failure (HF), particularly older women, have a preserved left ventricular ejection fraction (HFpEF). Patients with HFpEF have severe symptoms of exercise intolerance, poor quality-of-life, …
The majority of older patients who develop heart failure (HF), particularly older women, have a preserved left ventricular
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM, Cikes M, Prasad N, Li G, Getchevski S, Claggett B, Rizkala A, Lukashevich I, O'Meara E, Ryan JJ, Shah SJ, Mullens W, Zile MR, Lam CSP, McMurray JJV, Solomon SD; PARAGON-HF Investigators. Shah AM, et al. J Am Coll Cardiol. 2019 Dec 10;74(23):2858-2873. doi: 10.1016/j.jacc.2019.09.063. J Am Coll Cardiol. 2019. PMID: 31806129 Free article. Clinical Trial.
BACKGROUND: The PARAGON-HF (Prospective Comparison of ARNI With ARB Global Outcomes in HF With Preserved Ejection Fraction) trial tested the efficacy of sacubitril-valsartan in patients with heart failure with preserved ejection fraction (HFpEF) …
BACKGROUND: The PARAGON-HF (Prospective Comparison of ARNI With ARB Global Outcomes in HF With Preserved Ejection Fraction) tr …
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.
Hsu JJ, Ziaeian B, Fonarow GC. Hsu JJ, et al. JACC Heart Fail. 2017 Nov;5(11):763-771. doi: 10.1016/j.jchf.2017.06.013. Epub 2017 Oct 11. JACC Heart Fail. 2017. PMID: 29032140 Free PMC article. Review.
Heart failure (HF) with borderline ejection fraction was first defined in 2013 in the American College of Cardiology/American Heart Association guidelines as the presence of the typical symptoms of HF and a left ventricular ejection fraction
Heart failure (HF) with borderline ejection fraction was first defined in 2013 in the American College of Cardiology/American …
Pathophysiology and Echocardiographic Diagnosis of Left Ventricular Diastolic Dysfunction.
Silbiger JJ. Silbiger JJ. J Am Soc Echocardiogr. 2019 Feb;32(2):216-232.e2. doi: 10.1016/j.echo.2018.11.011. J Am Soc Echocardiogr. 2019. PMID: 30717860 Review.
Echocardiography is the primary imaging modality used for the clinical evaluation of left ventricular (LV) diastolic function. Using two-dimensional together with transmitral, mitral annular, and pulmonary venous Doppler data, conclusions may be drawn regarding the …
Echocardiography is the primary imaging modality used for the clinical evaluation of left ventricular (LV) diastolic function. …
[Heart failure with preserved ejection fraction (HFpEF)].
Maeder MT, Buser M, Brenner R, Rickli H. Maeder MT, et al. Ther Umsch. 2018 Sep;75(3):161-169. doi: 10.1024/0040-5930/a000983. Ther Umsch. 2018. PMID: 30145974 Review. German.
Heart failure with preserved ejection fraction (HFpEF) Abstract. Heart failure with preserved left ventricular ejection fraction (HFpEF) is a very common form of heart failure typically seen in older patients and associated …
Heart failure with preserved ejection fraction (HFpEF) Abstract. Heart failure with preserved left ventricula
Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
Abdul-Rahim AH, Shen L, Rush CJ, Jhund PS, Lees KR, McMurray JJV; VICCTA-Heart Failure Collaborators. Abdul-Rahim AH, et al. Eur J Heart Fail. 2018 Jul;20(7):1139-1145. doi: 10.1002/ejhf.1160. Epub 2018 Mar 1. Eur J Heart Fail. 2018. PMID: 29493058 Free article. Clinical Trial.
AIMS: To evaluate the effects of digoxin in patients with the newly described phenotype of heart failure (HF) and mid-range ejection fraction (HFmrEF), attributed to mild left ventricular systolic dysfunction. METHODS AND RESULTS: We carried out a retr …
AIMS: To evaluate the effects of digoxin in patients with the newly described phenotype of heart failure (HF) and mid-range ejection
Heart failure with preserved ejection fraction: controversies, challenges and future directions.
Zakeri R, Cowie MR. Zakeri R, et al. Heart. 2018 Mar;104(5):377-384. doi: 10.1136/heartjnl-2016-310790. Epub 2018 Jan 5. Heart. 2018. PMID: 29305560 Free article. Review.
Heart failure with preserved ejection fraction (HFpEF) comprises almost half of the population burden of HF. Because HFpEF likely includes a range of cardiac and non-cardiac abnormalities, typically in elderly patients, obtaining an accurate diagnosis …
Heart failure with preserved ejection fraction (HFpEF) comprises almost half of the population burden of HF. Because …
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, Paulus WJ, Pieske B, Piepoli MF, Ruschitzka F, Rutten FH, Seferovic PM, Solomon SD, Shah SJ, Triposkiadis F, Wachter R, Tschöpe C, de Boer RA. Gorter TM, et al. Eur J Heart Fail. 2018 Jan;20(1):16-37. doi: 10.1002/ejhf.1029. Epub 2017 Oct 16. Eur J Heart Fail. 2018. PMID: 29044932 Free article. Review.
There is an unmet need for effective treatment strategies to reduce morbidity and mortality in patients with heart failure with preserved ejection fraction (HFpEF). Until recently, attention in patients with HFpEF was almost exclusively focused on the …
There is an unmet need for effective treatment strategies to reduce morbidity and mortality in patients with heart failure with preserved …
The pathophysiology of heart failure with preserved ejection fraction.
Borlaug BA. Borlaug BA. Nat Rev Cardiol. 2014 Sep;11(9):507-15. doi: 10.1038/nrcardio.2014.83. Epub 2014 Jun 24. Nat Rev Cardiol. 2014. PMID: 24958077 Review.
Approximately half of all patients with heart failure have preserved ejection fraction (HFpEF) and, as life expectancies continue to increase in western societies, the prevalence of HFpEF will continue to grow. In contrast to heart failure with reduced …
Approximately half of all patients with heart failure have preserved ejection fraction (HFpEF) and, as life expectancie …
1,636 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page